ADURO BIOTECH — Lobbying Disclosure | Poliscope

ADURO BIOTECH

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2009–2020

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2020	—	4	1
2019	—	4	1
2018	—	8	2
2017	—	10	2
2016	—	7	2
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
INNOVATIVE FEDERAL STRATEGIES, LLC	—	49
U.S. GOVERNMENT RELATIONS INTL.	—	12

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	48
SENATE	48
Army, Dept of (Other)	4
Navy, Dept of	2
Vice President of the U.S.	2
Defense Threat Reduction Agency (DTRA)	1
Health & Human Services, Dept of (HHS)	1
U.S. Agency for International Development (USAID)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	32
Government Issues	Government Issues	17
Defense	Defense	16
Pharmacy	Pharmacy	11
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	3
Indian/Native American Affairs	Indian/Native American Affairs	1
Health Issues	Health Issues	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5293114th Congress

Department of Defense Appropriations Act, 2017

2016 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5293 / S. 3000 Department of Defense Appropriations Act, 2017, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 5293

S. 3000114th Congress

Department of Defense Appropriations Act, 2017

2016 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5293 / S. 3000 Department of Defense Appropriations Act, 2017, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: S. 3000

H.R. 5293114th Congress

Department of Defense Appropriations Act, 2017

2016 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5293 / S. 3000 Department of Defense Appropriations Act, 2017, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 5293

S. 3000114th Congress

Department of Defense Appropriations Act, 2017

2016 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5293 / S. 3000 Department of Defense Appropriations Act, 2017, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: S. 3000

Show 21 more cited filings

H.R. 5293114th Congress

Department of Defense Appropriations Act, 2017

2016 · second_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5293 / S. 3000 Department of Defense Appropriations Act, 2017, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 5293

S. 3000114th Congress

Department of Defense Appropriations Act, 2017

2016 · second_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5293 / S. 3000 Department of Defense Appropriations Act, 2017, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: S. 3000

H.R. 2685114th Congress

Department of Defense Appropriations Act, 2016

2015 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 2685

S. 1558114th Congress

Department of Defense Appropriations Act, 2016

2015 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: S. 1558

H.R. 2685114th Congress

Department of Defense Appropriations Act, 2016

2015 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 2685

S. 1558114th Congress

Department of Defense Appropriations Act, 2016

2015 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: S. 1558

H.R. 2685114th Congress

Department of Defense Appropriations Act, 2016

2015 · second_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 2685

S. 1558114th Congress

Department of Defense Appropriations Act, 2016

2015 · second_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2685 / S. 1558, Department of Defense Appropriations Act, 2016, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $20,000

Matched citations: S. 1558

S. 1429113th Congress

Department of Defense Appropriations Act, 2014

2014 · second_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2397 / S. 1429, Department of Defense Appropriations Act, 2015, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $10,000

Matched citations: S. 1429

S. 1429113th Congress

Department of Defense Appropriations Act, 2014

2013 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2397 / S. 1429, Department of Defense Appropriations Act, 2014, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $10,000

Matched citations: S. 1429

S. 1429113th Congress

Department of Defense Appropriations Act, 2014

2013 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2397 / S. 1429, Department of Defense Appropriations Act, 2014, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

Client expense: — · Firm income: $10,000

Matched citations: S. 1429

H.R. 5136110th Congress

To amend the Harmonized Tariff Schedule of the United States to permit foreign jewelry manufacturers who purchase precious metals produced in the United States for use in the manufacture of jewelry abroad to pay import duties on the value of the imported jewelry articles less the value of all United States origin precious metals incorporated in the article.

2010 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 5136 / S 3454, National Defense Authorization Act, 2011, all provisions relating to cancer and biodefense vaccines.

Client expense: — · Firm income: $10,000

Matched citations: HR 5136

S. 3686111th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011

2010 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR ____ / S 3800, Department of Defense Appropriations Act, 2011, Title IV, all provisions relating to cancer and biodefense vaccines. HR ____ / S 3686, Department of Labor, Health and Human Services Act, 2011, Title II, all provisions relating to cancer and infectious diseases.

Client expense: — · Firm income: $10,000

Matched citations: S 3686

S. 3800111th Congress

Department of Defense Appropriations Act, 2011

2010 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR ____ / S 3800, Department of Defense Appropriations Act, 2011, Title IV, all provisions relating to cancer and biodefense vaccines. HR ____ / S 3686, Department of Labor, Health and Human Services Act, 2011, Title II, all provisions relating to cancer and infectious diseases.

Client expense: — · Firm income: $10,000

Matched citations: S 3800

H.R. 5136110th Congress

2010 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 5136 / S 3454, National Defense Authorization Act, 2011, all provisions relating to cancer and biodefense vaccines.

Client expense: — · Firm income: $10,000

Matched citations: HR 5136

S. 3686111th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011

2010 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR ____ / S 3800, Department of Defense Appropriations Act, 2011, Title IV, all provisions relating to cancer and biodefense vaccines. HR ____ / S 3686, Department of Labor, Health and Human Services Act, 2011, Title II, all provisions relating to cancer and infectious diseases.

Client expense: — · Firm income: $10,000

Matched citations: S 3686

S. 3800111th Congress

Department of Defense Appropriations Act, 2011

2010 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR ____ / S 3800, Department of Defense Appropriations Act, 2011, Title IV, all provisions relating to cancer and biodefense vaccines. HR ____ / S 3686, Department of Labor, Health and Human Services Act, 2011, Title II, all provisions relating to cancer and infectious diseases.

Client expense: — · Firm income: $10,000

Matched citations: S 3800

H.R. 5136110th Congress

2010 · second_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts